EHR

Harnessing the Power of Real-World Data for New Therapies, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into the impact high-quality RWD can play when bringing a new therapy to market.…

3 months ago

Luma Celebrates Record Year of Customer Impact, International Expansion

Health systems use Luma to reach one-third of the U.S. population — and expand digital access globally SAN FRANCISCO, Oct. 28,…

3 months ago

Redox Announces Expansion of Core Platform to Power Smarter Interoperability Workflows

MADISON, Wis., Oct. 28, 2025 /PRNewswire/ -- Redox, a leader in healthcare data interoperability, today announced the evolution of the…

3 months ago

Soleno Therapeutics to Participate in Upcoming November Conferences

REDWOOD CITY, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel…

3 months ago

STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear® in Mexico and First Commercial Placements

HORSHAM, Pa., Oct. 28, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a global leader in in-office dermatologic…

3 months ago

REPEAT – MEDIA ADVISORY: Patients join Day of Action at Ontario Legislature to demand action on complaints about private clinics’ charges

TORONTO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- On Wednesday October 29, patients who have been wrongfully charged for surgeries and…

3 months ago

Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness

Policy opinion leaders believe a biological attack is both more likely and easier to execute than a nuclear strike, highlighting…

3 months ago

Evidence Against Evidence: CERN-IEEE FPGA vs. Crosetto 3D-Flow, a Breakthrough Invention Recognized 32 Years Ago That Could Have, and Can Still, Save Billions of Euros and Millions of Lives

Science vs. Consensus: An urgent call to CERN, IEEE, and the scientific community to engage with verifiable evidence, fulfill scientific…

3 months ago

TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI

NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in…

3 months ago

ISPE Names CSL Behring the 2025 ISPE Facility of the Year Awards (FOYA) Overall Winner for its Project Aurora Plasma Base Fractionation Facility (Facility F)

CSL Behring has been honored with this prestigious award recognizing innovation and excellence in pharmaceutical facility projects, as the FOYA…

3 months ago